Onco-Cardiology
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: patients with agreement for this study
Exclusion criteria
Exclusion criteria: 1patients without agrreement for this study 2inappropiriate patients determined from study director
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cardiac function, hemodynamics, frailty and depressive disorder score by PHQ-9 within one month from first visit | — |
Secondary
| Measure | Time frame |
|---|---|
| 1all cause death 2heart failure event 3artery thromboembolus event 4venous thromboembolus event 5Bleeding event 6blood pressere worsening | — |
Countries
Japan
Contacts
Department of cardiology office Department of cardiology office